Market news

Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return during that period. This may have investors wondering how to approach the situation.

Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.

Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year run, investors are increasingly focused on what its earnings actually justify. Cardinal Health has returned about 378.2% over the past 5 years, which puts real pressure on the current valuation story to be supported by the earnings profile. The...

CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.

Profiles 3M, Medline, Cardinal Health, Medtronic and DuPont, covering competitors, segments, regional shares, trends and opportunities. Medical Textile Market Medical Textile Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Medical Textile Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Medical Textile Market to Reach $64.28 Billion by 2030 as Healthcare Demand Accelerates The global medical textile market is experiencing exponential growth, supported by rising

Detailed price information for Mckesson Corp (MCK-N) from The Globe and Mail including charting and trades.

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period. Speaking at the Morgan Stanley Global Healthcare Confere

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027 guidance reflects continued growth from a more normalized base. Speaking at a Baird event, Hollar said t

Healthcare services and products company Cardinal Health (NYSE:CAH)’s shares are up by more than 10% year-to-date but are down by more than 8% since early September. Cramer discussed the firm’s share price performance in his morning appearance on September 15th and wondered whether the weakness was due to a rotation into AI stocks rather than […]

Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.

On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]

Detailed price information for Mckesson Corp (MCK-N) from The Globe and Mail including charting and trades.

Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic medical center, Places First Order for LockeT, VTAK’s suture retention device Places its first VIVO 3D Imaging System with a hospital in Germany, one of the largest electrophysiology markets in Europe. FORT MILL, S.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc.’s (NYSE American: VTAK) m

In August 2026, Cardinal Health reported fourth‑quarter sales of US$63,672 million and net income of US$398 million, alongside a new US$4.00 billion revolving credit facility, a fresh US$5.00 billion share repurchase authorization, and a regular quarterly dividend of US$0.5158 per share. Together with over US$2.08 billion already spent to retire approximately 5.7% of its shares, this combination of earnings growth, expanded liquidity, and stepped-up capital returns highlights management’s...

Detailed price information for Kinder Morgan Inc (KMI-N) from The Globe and Mail including charting and trades.

CAH enters fiscal 2027 with strong specialty growth, but IRA pricing changes, GMPD challenges and heavy CapEx pose risks.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and its peers.

Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.

Weitzman's equity reduction follows a 57% one-year stock price surge, leaving her with $18.3 million in direct holdings.

Alt divested part of his direct equity stake after the stock surged 57% over the past year, retaining 20,495 shares worth $4.82 million.

This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.

Michelle Greene reduced her direct equity stake following strong stock appreciation, retaining 10,330 shares worth $2.43 million.

Jessica Mayer holds 33,076 shares valued at $7.77 million.

Hollar divested 125,000 shares across two trading sessions, reducing his direct holdings following a 58% one-year stock surge.